Source disclosure: January 28, 2026
JCR Pharmaceuticals Co., Ltd. [4552.T]
TOKYO, Jan 28 (Pulse News Wire) – JCR Pharmaceuticals CO.,LTD. (4552.T) reported a special gain of ¥1.4 billion in its fiscal third quarter ending October 01, 2025.
The gain stems from confirmed government grants related to the construction of its Kobe Science Park Center facility. The company disclosed that the grant funds previously recorded in deferred revenue accounts were adjusted for asset compression entries and unused return amounts.
AI-translated content. 🟢 Confidence: High See terms • Original filing
💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.